RVMD
Revolution Medicines Inc
NASDAQ · Biotechnology
$97.49
+1.34 (+1.39%)
Performance
1D
—
1W
+0.34%
1M
-16.80%
3M
+52.14%
6M
+170.28%
1Y
+131.79%
YTD
+23.37%
Open$97.50
Previous Close$96.15
Day High$99.58
Day Low$96.43
52W High$124.49
52W Low$29.17
Volume2.10M
Avg Volume3.29M
Market Cap18.85B
P/E Ratio—
EPS$-2.73
SectorBiotechnology
Volume Analysis
0.64x average volume
Technical Indicators
SMA 50
$91.48
Above
SMA 200
$55.88
Above
RSI (14)
20
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
20 analysts
Price Target
+17.0% upside
Current
$97.49
$97.49
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.27B | 6.60B | 6.07B |
| Net Income | 320.45M | 295.32M | 319.17M |
| Profit Margin | 4.4% | 4.5% | 5.3% |
| EBITDA | 413.26M | 366.06M | 402.03M |
| Free Cash Flow | 328.07M | 289.36M | 393.55M |
| Rev Growth | +0.4% | +7.5% | +13.8% |
| Debt/Equity | 0.86 | 0.80 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |